Skip to main content
Erschienen in: ästhetische dermatologie & kosmetologie 4/2018

14.08.2018 | fortbildung

Faltenbehandlung

Hyaluron-Filler in der Dermatologie

verfasst von: Dr. Wolfgang G. Philipp-Dormston

Erschienen in: ästhetische dermatologie & kosmetologie | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Filler auf der Basis von Hyaluronsäure (HA-Filler) sind die am häufigsten verwendeten „Soft-Tissue-Filler“. Profunde anatomische Grundkenntnisse der Gesichtsregion und deren Alterungsprozesse, die geeignete Patientenauswahl, sichere HA-Filler, weitreichende Erfahrung in den Injektionstechniken und umfassendes Wissen in der Vorbeugung und Behandlung von möglichen Komplikationen sind essenzielle Grundvoraussetzungen dieses komplexen Therapieverfahrens.
Literatur
1.
Zurück zum Zitat Raspaldo H (2008) Volumizing effectof anewhyaluronic acidsubdermal facial filler: a retrospective analysis based on 102 cases. J Cosmet Laser Ther 10:134–142 CrossRefPubMed Raspaldo H (2008) Volumizing effectof anewhyaluronic acidsubdermal facial filler: a retrospective analysis based on 102 cases. J Cosmet Laser Ther 10:134–142 CrossRefPubMed
2.
Zurück zum Zitat Philipp-Dormston WG, Eccleston D, De Boulle K et al (2014) A prospective, observational study of the volumizing effect of openlabel aesthetic use of Juvéderm® VOLUMA® with Lidocaine in midface area. J Cosmet Laser Ther 16:171–179 CrossRefPubMed Philipp-Dormston WG, Eccleston D, De Boulle K et al (2014) A prospective, observational study of the volumizing effect of openlabel aesthetic use of Juvéderm® VOLUMA® with Lidocaine in midface area. J Cosmet Laser Ther 16:171–179 CrossRefPubMed
3.
Zurück zum Zitat Philipp-Dormston WG, Wong C, Schuster B et al (2017) Evaluating perceived naturalness of facial expression after fillers to the nasolabial folds and lower face with standardized video and photography. Dermatol Surg. https://​doi.​org/​10.​ 1097/DSS.0000000000001419 Philipp-Dormston WG, Wong C, Schuster B et al (2017) Evaluating perceived naturalness of facial expression after fillers to the nasolabial folds and lower face with standardized video and photography. Dermatol Surg. https://​doi.​org/​10.​ 1097/DSS.0000000000001419
4.
Zurück zum Zitat Prager W, Wissmueller E, Havermann I et al (2012) A prospective, split-face, randomized, comparative study of safety and 12-month longevity of three formulations of hyaluronic acid dermal filler for treatment of nasolabial folds. Dermatol Surg 38(7Pt 2):1143–1150 CrossRefPubMed Prager W, Wissmueller E, Havermann I et al (2012) A prospective, split-face, randomized, comparative study of safety and 12-month longevity of three formulations of hyaluronic acid dermal filler for treatment of nasolabial folds. Dermatol Surg 38(7Pt 2):1143–1150 CrossRefPubMed
5.
Zurück zum Zitat Philipp-Dormston WG, Hilton S, Nathan M (2014) A prospective, open-label, multicenter, observational, postmarket study of the use of a 15mg/mL hyaluronic acid dermal filler in the lips. J Cosmet Dermatol 13:125–134 CrossRefPubMedPubMedCentral Philipp-Dormston WG, Hilton S, Nathan M (2014) A prospective, open-label, multicenter, observational, postmarket study of the use of a 15mg/mL hyaluronic acid dermal filler in the lips. J Cosmet Dermatol 13:125–134 CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Lorenc ZP, Fagien S, Flynn TC et al (2013) Review of key Belotero balance safety and efficacy trials. Plast Reconstr Surg 132(4 Suppl. 2):33S–40S CrossRefPubMed Lorenc ZP, Fagien S, Flynn TC et al (2013) Review of key Belotero balance safety and efficacy trials. Plast Reconstr Surg 132(4 Suppl. 2):33S–40S CrossRefPubMed
7.
8.
Zurück zum Zitat Selyanin MA, Boykov P, Khabarov V et al (2015) The history of hyaluronic acid discovery, foundational research and initial use, in hyaluronic acid: preparation, properties, application in biology and medicine. John Wiley & Sons, Ltd, Chichester, S1–7 Selyanin MA, Boykov P, Khabarov V et al (2015) The history of hyaluronic acid discovery, foundational research and initial use, in hyaluronic acid: preparation, properties, application in biology and medicine. John Wiley & Sons, Ltd, Chichester, S1–7
9.
10.
Zurück zum Zitat Balazs EA, Denlinger JL (1989) Clinical uses of hyaluronan. Ciba Found Symp 143:265–275 PubMed Balazs EA, Denlinger JL (1989) Clinical uses of hyaluronan. Ciba Found Symp 143:265–275 PubMed
11.
Zurück zum Zitat Piacquadio P (1994) Crosslinked hyaluronic acid (Hylan gel) as a soft tissue augmentation material: a preliminary assessment. In: Elson ML (Hrsg) Evaluation and treatment of the aging face. Springer, New York, S304–308 Piacquadio P (1994) Crosslinked hyaluronic acid (Hylan gel) as a soft tissue augmentation material: a preliminary assessment. In: Elson ML (Hrsg) Evaluation and treatment of the aging face. Springer, New York, S304–308
12.
Zurück zum Zitat Andre P, Lowe NJ, Parc Aet al (2005) Adverse reactions to dermal fillers: a review of European experiences. JCosmet Laser Ther 7:171–176 CrossRef Andre P, Lowe NJ, Parc Aet al (2005) Adverse reactions to dermal fillers: a review of European experiences. JCosmet Laser Ther 7:171–176 CrossRef
13.
Zurück zum Zitat Rohrich RJ, Monheit G, Nguyen AT et al (2010) Soft-tissue filler complications: the important role of biofilms. Plast Reconstr Surg 125:1250–1256 PubMed Rohrich RJ, Monheit G, Nguyen AT et al (2010) Soft-tissue filler complications: the important role of biofilms. Plast Reconstr Surg 125:1250–1256 PubMed
14.
Zurück zum Zitat Ballin AC, Brandt FS, Cazzaniga A (2015) Dermal fillers: an update. Am J Clin Dermatol 16:271–283 CrossRefPubMed Ballin AC, Brandt FS, Cazzaniga A (2015) Dermal fillers: an update. Am J Clin Dermatol 16:271–283 CrossRefPubMed
15.
Zurück zum Zitat Falcone SJ, Berg RA (2008) Crosslinked hyaluronic acid dermal fillers: a comparison of rheological properties. J Biomed Mater Res 87:264–271 CrossRef Falcone SJ, Berg RA (2008) Crosslinked hyaluronic acid dermal fillers: a comparison of rheological properties. J Biomed Mater Res 87:264–271 CrossRef
16.
Zurück zum Zitat De Boulle K, Glogau R, Kono T et al (2013) A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers. Dermatol Surg 39:1758–1766 CrossRefPubMedPubMedCentral De Boulle K, Glogau R, Kono T et al (2013) A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers. Dermatol Surg 39:1758–1766 CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Tezel A, Fredrickson GH (2008) The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther 10:35–42 CrossRefPubMed Tezel A, Fredrickson GH (2008) The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther 10:35–42 CrossRefPubMed
18.
Zurück zum Zitat Buntrock H, Reuther T, Prager W, Kerscher M (2013) Efficacy, safety, and patient satisfaction of a monophasic cohesive polydensified matrix versus a biphasic non animal stabilized hyaluronic acid filler after single injection in nasolabial folds. Dermatol Surg 39(7):1097–1105 CrossRefPubMed Buntrock H, Reuther T, Prager W, Kerscher M (2013) Efficacy, safety, and patient satisfaction of a monophasic cohesive polydensified matrix versus a biphasic non animal stabilized hyaluronic acid filler after single injection in nasolabial folds. Dermatol Surg 39(7):1097–1105 CrossRefPubMed
19.
Zurück zum Zitat Landau M, Fagien S (2015) Science of hyaluronic acid beyond filling: fibroblasts and their response to the extracellular matrix. Plast Reconstr Surg 136(5Suppl):188S–195S CrossRefPubMed Landau M, Fagien S (2015) Science of hyaluronic acid beyond filling: fibroblasts and their response to the extracellular matrix. Plast Reconstr Surg 136(5Suppl):188S–195S CrossRefPubMed
20.
Zurück zum Zitat Muhn Ch, Rosen N, Solish N et al (2012) The evolving role of hyaluronic acid fillers for facial volume restoration and contouring: a Canadian overview. Clin Cosmet Investig Dermatol 5:147–158 CrossRefPubMedPubMedCentral Muhn Ch, Rosen N, Solish N et al (2012) The evolving role of hyaluronic acid fillers for facial volume restoration and contouring: a Canadian overview. Clin Cosmet Investig Dermatol 5:147–158 CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Borell M, Leslie DB, Tezel A, a (2011) Lift capabilities of hyaluronic acid fillers. J Cosmet Laser Ther 13:21–27 CrossRef Borell M, Leslie DB, Tezel A, a (2011) Lift capabilities of hyaluronic acid fillers. J Cosmet Laser Ther 13:21–27 CrossRef
22.
Zurück zum Zitat De Lorenzi C (2017) New high dose pulsed hyaluronidase protocol for hyaluronic acid filler vascular adverse events. Aesthet Surg J 37(7):814–825 CrossRef De Lorenzi C (2017) New high dose pulsed hyaluronidase protocol for hyaluronic acid filler vascular adverse events. Aesthet Surg J 37(7):814–825 CrossRef
23.
Zurück zum Zitat Hilton S, Schrumpf H, Buhren BA et al (2014) Hyaluronidase injection for the treatment of eyelid edema: a retrospective analysis of 20 patients. Eur J Med Res 19:30 CrossRefPubMedPubMedCentral Hilton S, Schrumpf H, Buhren BA et al (2014) Hyaluronidase injection for the treatment of eyelid edema: a retrospective analysis of 20 patients. Eur J Med Res 19:30 CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Kim DW, Yoon ES, Ji YH et al (2011) Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management. J Plast Reconstr Aesthet Surg 64:1590–1595 CrossRefPubMed Kim DW, Yoon ES, Ji YH et al (2011) Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management. J Plast Reconstr Aesthet Surg 64:1590–1595 CrossRefPubMed
25.
Zurück zum Zitat Philipp-Dormston WG, Bergfeld D, Sommer BM et al (2017) Consensus statement on prevention and management of adverse effects following rejuvenation procedures with hyaluronic acid-based fillers. J Eur Acad Dermatol Venereol 31:1088–1095 CrossRefPubMed Philipp-Dormston WG, Bergfeld D, Sommer BM et al (2017) Consensus statement on prevention and management of adverse effects following rejuvenation procedures with hyaluronic acid-based fillers. J Eur Acad Dermatol Venereol 31:1088–1095 CrossRefPubMed
26.
Zurück zum Zitat Philipp-Dormston WG, Bergfeld D, Sommer B (2013) Konsensus empfehlungen zur Behandlung mit Onabotulinumtoxin A in der ästhetischen Medizin. J Dtsch Dermatol Ges 11(Suppl. 1):1–42 Philipp-Dormston WG, Bergfeld D, Sommer B (2013) Konsensus empfehlungen zur Behandlung mit Onabotulinumtoxin A in der ästhetischen Medizin. J Dtsch Dermatol Ges 11(Suppl. 1):1–42
27.
Zurück zum Zitat Carruthers JD, Fagien S, Rohrich RJ et al (2014) Blindness caused by cosmetic filler injection: a review of cause and therapy. Plast Reconstr Surg 134(6):1197–1201 CrossRefPubMed Carruthers JD, Fagien S, Rohrich RJ et al (2014) Blindness caused by cosmetic filler injection: a review of cause and therapy. Plast Reconstr Surg 134(6):1197–1201 CrossRefPubMed
28.
Zurück zum Zitat Carruthers J, Fagien S, Dolman P (2015) Retro or peribulbar injection techniques to reverse visual loss after filler injections. Dermatol Surg 41(Suppl1):S354–S357 CrossRefPubMed Carruthers J, Fagien S, Dolman P (2015) Retro or peribulbar injection techniques to reverse visual loss after filler injections. Dermatol Surg 41(Suppl1):S354–S357 CrossRefPubMed
29.
Zurück zum Zitat Pessa RRJJE (2007) The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg 119:2219–2227 CrossRefPubMed Pessa RRJJE (2007) The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg 119:2219–2227 CrossRefPubMed
30.
Zurück zum Zitat Wulc AE, Sharma P, Czyz CN (2012) The anatomic basis of midfacial aging. In: Hartstein Wulc Holck M E M D A E D E (Hrsg) Midfacial rejuvenation. Springer, Heidelberg, S 15–28 https://​doi.​org/​10.​1007/​978-1-4614-1007-2_​2 CrossRef Wulc AE, Sharma P, Czyz CN (2012) The anatomic basis of midfacial aging. In: Hartstein Wulc Holck M E M D A E D E (Hrsg) Midfacial rejuvenation. Springer, Heidelberg, S 15–28 https://​doi.​org/​10.​1007/​978-1-4614-1007-2_​2 CrossRef
31.
Zurück zum Zitat Le Louarn C, Buthiau D, Buis J (2007) Structural aging: the facial recurve concept. Aesthetic Plast Surg 31:213–218 CrossRefPubMed Le Louarn C, Buthiau D, Buis J (2007) Structural aging: the facial recurve concept. Aesthetic Plast Surg 31:213–218 CrossRefPubMed
32.
Zurück zum Zitat Coleman SR, Grover R (2006) The anatomy of the aging face: volume loss and changes in 3-dimensional topography. Aesthet Surg J 26:4–9 CrossRef Coleman SR, Grover R (2006) The anatomy of the aging face: volume loss and changes in 3-dimensional topography. Aesthet Surg J 26:4–9 CrossRef
33.
Zurück zum Zitat Callan P, Goodman GJ, Carlisle I et al (2013) Efficacy and safety of a hyaluronic acid filler in subjects treated for correction of midface volume deficiency: a 24 month study. Clin Cosmet Investig Dermatol 20:81–89 CrossRef Callan P, Goodman GJ, Carlisle I et al (2013) Efficacy and safety of a hyaluronic acid filler in subjects treated for correction of midface volume deficiency: a 24 month study. Clin Cosmet Investig Dermatol 20:81–89 CrossRef
Metadaten
Titel
Faltenbehandlung
Hyaluron-Filler in der Dermatologie
verfasst von
Dr. Wolfgang G. Philipp-Dormston
Publikationsdatum
14.08.2018
Verlag
Springer Medizin
Erschienen in
ästhetische dermatologie & kosmetologie / Ausgabe 4/2018
Print ISSN: 1867-481X
Elektronische ISSN: 2198-6517
DOI
https://doi.org/10.1007/s12634-018-5659-4

Weitere Artikel der Ausgabe 4/2018

ästhetische dermatologie & kosmetologie 4/2018 Zur Ausgabe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Dermatologie und bleiben Sie gut informiert – ganz bequem per eMail.